ReproCELL Incorporated
Research ReproCELL Incorporated (6RC) on Bullrun: market cap EUR 43.33M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6RC
- ExchangeF
- CountryJapan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 43.33M
- Financial periodFY2025
- RevenueEUR 2.98B
- Revenue growth22.7%
- Net incomeEUR 103.25M
- Free cash flow-EUR 89.86M
- Gross margin55.4%
Valuation Snapshot
latest market cap is EUR 43.33M.
About ReproCELL Incorporated
ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents;
Frequently asked questions
What is ReproCELL Incorporated's market cap?
ReproCELL Incorporated's market capitalization is EUR 43.33M.
What does ReproCELL Incorporated do?
ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and...